Abstract
Aims Diabetes is one of the leading causes of morbidity and mortality in the United States and worldwide. This research aimed to develop an artificial intelligence (AI) machine learning model which can detect the presence of diabetes from fundus imagery of eyes without diabetic eye disease.
Methods Our researchers trained a machine learning algorithm on the EyePACS dataset, consisting of 47,076 images. Patients were also divided into cohorts based on disease duration, each cohort consisting of patients diagnosed within the timeframe in question (e.g., 15 years) and healthy patients.
Results The algorithm achieved 0.83 area under receiver operating curve (AUC) in detecting diabetes per image, and AUC 0.86 on the task of detecting diabetes per patient.
Conclusion Our results suggest that diabetes may be diagnosed non-invasively using fundus imagery alone. This may enable diabetes diagnosis at point of care, as well as other, accessible venues, facilitating the diagnosis of many undiagnosed people with diabetes.
Competing Interest Statement
YR and RA are employees of AEYE Health. ZD-A is CEO of AEYE Health.
Funding Statement
This study was funded by AEYE Health, Inc.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board exemption was obtained from the Sterling Independent Review Board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data may be obtained from a third party and are not publicly available. De-identified data used in this study are not publicly available at present. Parties interested in data access should contact JC (jcuadros{at}eyepacs.com) for queries related to EyePACS. Applications will need to undergo ethical and legal approvals by the respective institutions.
